Skip to main content
SpringerLink
Log in

Osteosarcoma

  • Chapter
  • First Online:
Orthopaedic Oncology

Part of the book series: Cancer Treatment and Research ((CTAR,volume 162))

Abstract

Osteosarcoma is a malignant tumor that primarily affects the long bones but can also involve other bones in the body.  It has a bimodal distribution with peaks in the second decade of life and late adulthood.  This chapter will highlight the clinical presentation, diagnosis, and treatment of osteosarcoma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Enneking WF (2009) History of orthopedic oncology in the United States. In: Pediatric and adolescent osteosarcoma. Cancer treatment and research. Springer, New York, pp 531–534

    Google Scholar 

  2. Boyer Alexis (1805) The lectures of Boyer upon disease of the bone. James Humphreys, Philadelphia

    Google Scholar 

  3. Dupuytren Guillaume (1847) On injuries and diseases of bones. Sydenham Society, London

    Google Scholar 

  4. Lebert H (1845) Physiologie pathologiques des recherches cliniques, on experimentales et microscopiques, etc. JB Bailliere, Paris

    Google Scholar 

  5. Virchow Rudolf (1867) Die Krankenhaften Gewulstewulste. Hirschwald, Berlin

    Google Scholar 

  6. Gross SW (1879) Sarcoma of the long bones: based on a study of one hundreed sixty-five cases. Am J Med Sci 8:338–377

    Google Scholar 

  7. Codman E (1909) The use of the X-ray and radiation in surgery. In: Surgery, its principles and practice by various authors. WB Saunders, Philadelphia, p 1170

    Google Scholar 

  8. Phemister DB (1940) Conservative surgery in the treatment of bone tumors. Surg Gynecol Obstet 70:355–364

    Google Scholar 

  9. Mirabello L, Troisi RJ, Savage SA (2009) Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program. Cancer 115(7):1531–1543. doi:10.1002/cncr.24121

    PubMed Central  PubMed  Google Scholar 

  10. Iannaci G, Luise R, Sapere P, Costanzo RMA, Rossiello R (2013) Extraskeletal osteosarcoma: a very rare case report of primary tumor of the colon-rectum and review of the literature. Pathol Res Pract 209(6):393–396. doi:10.1016/j.prp.2013.03.010

    CAS  PubMed  Google Scholar 

  11. Kansara M, Thomas DM (2007) Molecular pathogenesis of osteosarcoma. DNA Cell Biol 26(1):1–18. doi:10.1089/dna.2006.0505

    CAS  PubMed  Google Scholar 

  12. Ottaviani G, Jaffe N (2002) Clinical and pathologic study of two siblings with osteosarcoma. Med Pediatr Oncol 38(1):62–64

    PubMed  Google Scholar 

  13. Wang LL (2005) Biology of osteogenic sarcoma. Cancer J Sudbury Mass 11(4):294–305

    CAS  Google Scholar 

  14. Hansen MF, Koufos A, Gallie BL et al (1985) Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition. Proc Natl Acad Sci USA 82(18):6216–6220

    CAS  PubMed Central  PubMed  Google Scholar 

  15. Wadayama B, Toguchida J, Shimizu T et al (1994) Mutation spectrum of the retinoblastoma gene in osteosarcomas. Cancer Res 54(11):3042–3048

    CAS  PubMed  Google Scholar 

  16. Li FP, Fraumeni JF Jr, Mulvihill JJ et al (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res 48(18):5358–5362

    CAS  PubMed  Google Scholar 

  17. Laurin N, Brown JP, Morissette J, Raymond V (2002) Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am J Hum Genet 70(6):1582–1588. doi:10.1086/340731

    CAS  PubMed Central  PubMed  Google Scholar 

  18. Ottaviani G, Jaffe N (2009) The etiology of osteosarcoma. Cancer Treat Res 152:15–32. doi:10.1007/978-1-4419-0284-9_2

    PubMed  Google Scholar 

  19. Rockwell MA, Enneking WF (1971) Osteosarcoma developing in solitary enchondroma of the tibia. J Bone Joint Surg Am 53(2):341–344

    CAS  PubMed  Google Scholar 

  20. Huvos AG, Higinbotham NL, Miller TR (1972) Bone sarcomas arising in fibrous dysplasia. J Bone Joint Surg Am 54(5):1047–1056

    CAS  PubMed  Google Scholar 

  21. Johnston RM, Miles JS (1973) Sarcomas arising from chronic osteomyelitic sinuses. A report of two cases. J Bone Joint Surg Am 55(1):162–168

    CAS  PubMed  Google Scholar 

  22. Le Vu B, de Vathaire F, Shamsaldin A et al (1998) Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood. Int J Cancer 77(3):370–377

    PubMed  Google Scholar 

  23. Shigematsu I (1994) Health effects of atomic bomb radiation. Rinsho Byori 42(4):313–319

    CAS  PubMed  Google Scholar 

  24. Fletcher CDM, Unni KK, World Health Organization, International Agency for Research on Cancer(2002) Pathology and genetics of tumours of soft tissue and bone. IARC Press, Lyon

    Google Scholar 

  25. Messerschmitt PJ, Garcia RM, Abdul-Karim FW, Greenfield EM, Getty PJ (2009) Osteosarcoma. J Am Acad Orthop Surg 17(8):515–527

    PubMed  Google Scholar 

  26. Klein MJ, Siegal GP (2006) Osteosarcoma: anatomic and histologic variants. Am J Clin Pathol 125(4):555–581. doi:10.1309/UC6K-QHLD-9LV2-KENN

    PubMed  Google Scholar 

  27. Yarmish G, Klein MJ, Landa J, Lefkowitz RA, Hwang S (2010) Imaging characteristics of primary osteosarcoma: nonconventional subtypes. Radiogr Rev Publ Radiol Soc North Am Inc 30(6):1653–1672. doi:10.1148/rg.306105524

    Google Scholar 

  28. Sangle NA, Layfield LJ (2012) Telangiectatic osteosarcoma. Arch Pathol Lab Med 136(5):572–576. doi:10.5858/arpa.2011-0204-RS

    PubMed  Google Scholar 

  29. Nakajima H, Sim FH, Bond JR, Unni KK (1997) Small cell osteosarcoma of bone. Review of 72 cases. Cancer 79(11):2095–2106

    CAS  PubMed  Google Scholar 

  30. Jacobson SA (1958) Early juxtacortical osteosarcoma (parosteal osteoma). J Bone Joint Surg Am 40-A(6):1310–1328

    Google Scholar 

  31. Okada K, Frassica FJ, Sim FH, Beabout JW, Bond JR, Unni KK (1994) Parosteal osteosarcoma. A clinicopathological study. J Bone Joint Surg Am 76(3):366–378

    CAS  PubMed  Google Scholar 

  32. Raymond AK (1991) Surface osteosarcoma. Clin Orthop 270:140–148

    PubMed  Google Scholar 

  33. Wold LE, Unni KK, Beabout JW, Sim FH, Dahlin DC (1984) Dedifferentiated parosteal osteosarcoma. J Bone Joint Surg Am 66(1):53–59

    CAS  PubMed  Google Scholar 

  34. Allan CJ, Soule EH (1971) Osteogenic sarcoma of the somatic soft tissues. Clinicopathologic study of 26 cases and review of literature. Cancer 27(5):1121–1133

    CAS  PubMed  Google Scholar 

  35. Kallianpur AA, Gupta R, Muduly DK, Kapali A, Subbarao KC (2013) Osteosarcoma of breast: a rare case of extraskeletal osteosarcoma. J Cancer Res Ther 9(2):292–294. doi:10.4103/0973-1482.113392

    PubMed  Google Scholar 

  36. Karagöz Özen DS, Oztürk MA, Selcukbiricik F, et al (2013) Primary osteosarcoma of the heart: experience of an unusual case. Case Reports Oncol 6(1):224–228. doi:10.1159/000351123

  37. Adamkova Krakorova D, Vesely K, Zambo I, et al (2012) Analysis of prognostic factors in osteosarcoma adult patients, a single institution experience. Klin Onkol Cas Ceské Slov Onkol Spolecnosti 25(5):346–358

    Google Scholar 

  38. Durnali A, Alkis N, Cangur S et al (2013) Prognostic factors for teenage and adult patients with high-grade osteosarcoma: an analysis of 240 patients. Med Oncol Northwood Lond Engl 30(3):624. doi:10.1007/s12032-013-0624-6

    Google Scholar 

  39. Dahlin DC, Unni KK (1986) Bone tumors: general aspects and data on 8,542 cases, 4th edn. Charles C. Thomas, Springfield

    Google Scholar 

  40. Fox MG, Trotta BM (2013) Osteosarcoma: review of the various types with emphasis on recent advancements in imaging. Semin Musculoskelet Radiol 17(2):123–136. doi:10.1055/s-0033-1342969

    PubMed  Google Scholar 

  41. Chuang VP, Benjamin R, Jaffe N et al (1982) Radiographic and angiographic changes in osteosarcoma after intraarterial chemotherapy. AJR Am J Roentgenol 139(6):1065–1069. doi:10.2214/ajr.139.6.1065

    CAS  PubMed  Google Scholar 

  42. Jaffe N, Spears R, Eftekhari F et al (1987) Pathologic fracture in osteosarcoma. Impact of chemotherapy on primary tumor and survival. Cancer 59(4):701–709

    CAS  PubMed  Google Scholar 

  43. Kager L, Zoubek A, Kastner U et al (2006) Skip metastases in osteosarcoma: experience of the Cooperative Osteosarcoma Study Group. J Clin Oncol Off J Am Soc Clin Oncol 24(10):1535–1541. doi:10.1200/JCO.2005.04.2978

    Google Scholar 

  44. Sajadi KR, Heck RK, Neel MD et al (2004) The incidence and prognosis of osteosarcoma skip metastases. Clin Orthop 426:92–96. doi:10.1097/01.blo.0000141493.52166.69

    PubMed  Google Scholar 

  45. Bacci G, Briccoli A, Rocca M et al (2003) Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide. Ann Oncol Off J Eur Soc Med Oncol ESMO. 14(7):1126–1134

    CAS  Google Scholar 

  46. Kager L, Zoubek A, Pötschger U et al (2003) Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol Off J Am Soc Clin Oncol 21(10):2011–2018. doi:10.1200/JCO.2003.08.132

    Google Scholar 

  47. Kayton ML, Huvos AG, Casher J, et al (2006) Computed tomographic scan of the chest underestimates the number of metastatic lesions in osteosarcoma. J Pediatr Surg 41(1):200–206; discussion 200–206. doi:10.1016/j.jpedsurg.2005.10.024

  48. Eary JF, Mankoff DA (1998) Tumor metabolic rates in sarcoma using FDG PET. J Nucl Med Off Publ Soc Nucl Med 39(2):250–254

    CAS  Google Scholar 

  49. Eary JF, O’Sullivan F, Powitan Y et al (2002) Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis. Eur J Nucl Med Mol Imaging 29(9):1149–1154. doi:10.1007/s00259-002-0859-5

    CAS  PubMed  Google Scholar 

  50. Franzius C, Sciuk J, Daldrup-Link HE, Jürgens H, Schober O (2000) FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy. Eur J Nucl Med 27(9):1305–1311

    CAS  PubMed  Google Scholar 

  51. Choyke PL, Dwyer AJ, Knopp MV (2003) Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging JMRI 17(5):509–520. doi:10.1002/jmri.10304

    Google Scholar 

  52. Guo J, Reddick WE, Glass JO et al (2012) Dynamic contrast-enhanced magnetic resonance imaging as a prognostic factor in predicting event-free and overall survival in pediatric patients with osteosarcoma. Cancer 118(15):3776–3785. doi:10.1002/cncr.26701

    PubMed Central  PubMed  Google Scholar 

  53. Kawai A, Sugihara S, Kunisada T, Uchida Y, Inoue H (1997) Imaging assessment of the response of bone tumors to preoperative chemotherapy. Clin Orthop 337:216–225

    PubMed  Google Scholar 

  54. Enneking WF, Spanier SS, Goodman MA (1980) A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop 153:106–120

    PubMed  Google Scholar 

  55. American Joint Committee on Cancer (2010) AJCC cancer staging manual, 7th edn. Springer, New York

    Google Scholar 

  56. Dahlin DC, Coventry MB (1967) Osteogenic sarcoma. A study of six hundred cases. J Bone Joint Surg Am 49(1):101–110

    CAS  PubMed  Google Scholar 

  57. Bacci G, Ferrari S, Bertoni F et al (2000) Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report. J Clin Oncol Off J Am Soc Clin Oncol 18(24):4016–4027

    CAS  Google Scholar 

  58. Link MP, Goorin AM, Miser AW et al (1986) The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 314(25):1600–1606. doi:10.1056/NEJM198606193142502

    CAS  PubMed  Google Scholar 

  59. Bernthal NM, Federman N, Eilber FR et al (2012) Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma. Cancer 118(23):5888–5893. doi:10.1002/cncr.27651

    CAS  PubMed  Google Scholar 

  60. Eilber F, Giuliano A, Eckardt J, Patterson K, Moseley S, Goodnight J (1987) Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial. J Clin Oncol Off J Am Soc Clin Oncol 5(1):21–26

    CAS  Google Scholar 

  61. Friedman MA, Carter SK (1972) The therapy of osteogenic sarcoma: current status and thoughts for the future. J Surg Oncol 4(5):482–510

    CAS  PubMed  Google Scholar 

  62. Ferguson WS, Goorin AM (2001) Current treatment of osteosarcoma. Cancer Invest 19(3):292–315

    CAS  PubMed  Google Scholar 

  63. Goorin AM, Perez-Atayde A, Gebhardt M et al (1987) Weekly high-dose methotrexate and doxorubicin for osteosarcoma: the Dana-Farber Cancer Institute/the Children’s Hospital–study III. J Clin Oncol Off J Am Soc Clin Oncol 5(8):1178–1184

    CAS  Google Scholar 

  64. Sutow WW (1980) Multidrug chemotherapy in osteosarcoma. Clin Orthop 153:67–72

    PubMed  Google Scholar 

  65. Taylor WF, Ivins JC, Pritchard DJ, Dahlin DC, Gilchrist GS, Edmonson JH (1985) Trends and variability in survival among patients with osteosarcoma: a 7-year update. Mayo Clin Proc Mayo Clin 60(2):91–104

    CAS  Google Scholar 

  66. Edmonson JH, Green SJ, Ivins JC et al (1984) A controlled pilot study of high-dose methotrexate as postsurgical adjuvant treatment for primary osteosarcoma. J Clin Oncol Off J Am Soc Clin Oncol 2(3):152–156

    CAS  Google Scholar 

  67. Maki RG (2012) Ifosfamide in the neoadjuvant treatment of osteogenic sarcoma. J Clin Oncol Off J Am Soc Clin Oncol 30(17):2033–2035. doi:10.1200/JCO.2012.42.3285

    CAS  Google Scholar 

  68. Ferrari S, Ruggieri P, Cefalo G et al (2012) Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1. J Clin Oncol Off J Am Soc Clin Oncol 30(17):2112–2118. doi:10.1200/JCO.2011.38.4420

    CAS  Google Scholar 

  69. Souhami RL, Craft AW, Van der Eijken JW et al (1997) Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet 350(9082):911–917. doi:10.1016/S0140-6736(97)02307-6

    CAS  PubMed  Google Scholar 

  70. Bramwell VH, Burgers M, Sneath R et al (1992) A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup. J Clin Oncol Off J Am Soc Clin Oncol 10(10):1579–1591

    CAS  Google Scholar 

  71. Rosen G, Marcove RC, Caparros B, Nirenberg A, Kosloff C, Huvos AG (1979) Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery. Cancer 43(6):2163–2177

    CAS  PubMed  Google Scholar 

  72. Bielack SS, Kempf-Bielack B, Delling G et al (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol Off J Am Soc Clin Oncol 20(3):776–790

    Google Scholar 

  73. Meyers PA, Heller G, Healey J et al (1992) Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol Off J Am Soc Clin Oncol 10(1):5–15

    CAS  Google Scholar 

  74. Bacci G, Picci P, Ruggieri P et al (1990) Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin. Cancer 65(11):2539–2553

    CAS  PubMed  Google Scholar 

  75. Malawer M, Buch R, Reaman G et al (1991) Impact of two cycles of preoperative chemotherapy with intraarterial cisplatin and intravenous doxorubicin on the choice of surgical procedure for high-grade bone sarcomas of the extremities. Clin Orthop 270:214–222

    PubMed  Google Scholar 

  76. Meyers PA, Schwartz CL, Krailo MD et al (2008) Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival–a report from the Children’s Oncology Group. J Clin Oncol Off J Am Soc Clin Oncol 26(4):633–638. doi:10.1200/JCO.2008.14.0095

    CAS  Google Scholar 

  77. Meyers PA, Schwartz CL, Krailo M et al (2005) Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol Off J Am Soc Clin Oncol 23(9):2004–2011. doi:10.1200/JCO.2005.06.031

    CAS  Google Scholar 

  78. Sampson VB, Gorlick R, Kamara D, Anders Kolb E (2013) A review of targeted therapies evaluated by the pediatric preclinical testing program for osteosarcoma. Front Oncol 3:132. doi:10.3389/fonc.2013.00132

    PubMed Central  PubMed  Google Scholar 

  79. Ling V (1997) Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother Pharmacol 40(Suppl):S3–S8

    CAS  PubMed  Google Scholar 

  80. Bacci G, Longhi A, Cesari M, Versari M, Bertoni F (2006) Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients. Cancer 106(12):2701–2706. doi:10.1002/cncr.21937

    PubMed  Google Scholar 

  81. Scully SP, Ghert MA, Zurakowski D, Thompson RC, Gebhardt MC (2002) Pathologic fracture in osteosarcoma: prognostic importance and treatment implications. J Bone Joint Surg Am 84-A(1):49–57

    Google Scholar 

  82. Rougraff BT, Simon MA, Kneisl JS, Greenberg DB, Mankin HJ (1994) Limb salvage compared with amputation for osteosarcoma of the distal end of the femur. A long-term oncological, functional, and quality-of-life study. J Bone Joint Surg Am 76(5):649–656

    CAS  PubMed  Google Scholar 

  83. Renard AJ, Veth RP, Schreuder HW, van Loon CJ, Koops HS, van Horn JR (2000) Function and complications after ablative and limb-salvage therapy in lower extremity sarcoma of bone. J Surg Oncol 73(4):198–205

    CAS  PubMed  Google Scholar 

  84. Otis JC, Lane JM, Kroll MA (1985) Energy cost during gait in osteosarcoma patients after resection and knee replacement and after above-the-knee amputation. J Bone Joint Surg Am 67(4):606–611

    CAS  PubMed  Google Scholar 

  85. Harris IE, Leff AR, Gitelis S, Simon MA (1990) Function after amputation, arthrodesis, or arthroplasty for tumors about the knee. J Bone Joint Surg Am 72(10):1477–1485

    CAS  PubMed  Google Scholar 

  86. Mason GE, Aung L, Gall S et al (2013) Quality of life following amputation or limb preservation in patients with lower extremity bone sarcoma. Front Oncol 3:210. doi:10.3389/fonc.2013.00210

    PubMed Central  PubMed  Google Scholar 

  87. Weddington WW Jr, Segraves KB, Simon MA (1985) Psychological outcome of extremity sarcoma survivors undergoing amputation or limb salvage. J Clin Oncol Off J Am Soc Clin Oncol 3(10):1393–1399

    Google Scholar 

  88. Henderson ER, Groundland JS, Pala E et al (2011) Failure mode classification for tumor endoprostheses: retrospective review of five institutions and a literature review. J Bone Joint Surg Am 93(5):418–429. doi:10.2106/JBJS.J.00834

    PubMed  Google Scholar 

  89. Horowitz SM, Glasser DB, Lane JM, Healey JH (1993) Prosthetic and extremity survivorship after limb salvage for sarcoma. How long do the reconstructions last? Clin Orthop 293:280–286

    PubMed  Google Scholar 

  90. Malawer MM, Chou LB (1995) Prosthetic survival and clinical results with use of large-segment replacements in the treatment of high-grade bone sarcomas. J Bone Joint Surg Am 77(8):1154–1165

    CAS  PubMed  Google Scholar 

  91. Mankin HJ, Gebhardt MC, Jennings LC, Springfield DS, Tomford WW (1996) Long-term results of allograft replacement in the management of bone tumors. Clin Orthop 324:86–97

    PubMed  Google Scholar 

  92. Berrey BH Jr, Lord CF, Gebhard MC, Mankin HJ (1990) Fractures of allografts. Frequency, treatment, and end-results. J Bone Joint Surg Am 72(6):825–833

    PubMed  Google Scholar 

  93. Sorger JI, Hornicek FJ, Zavatta M et al (2001) Allograft fractures revisited. Clin Orthop 382:66–74

    PubMed  Google Scholar 

  94. Hornicek FJ, Gebhardt MC, Tomford WW et al (2001) Factors affecting nonunion of the allograft-host junction. Clin Orthop 382:87–98

    PubMed  Google Scholar 

  95. Getty PJ, Peabody TD (1999) Complications and functional outcomes of reconstruction with an osteoarticular allograft after intra-articular resection of the proximal aspect of the humerus. J Bone Joint Surg Am 81(8):1138–1146

    CAS  PubMed  Google Scholar 

  96. Abdeen A, Hoang BH, Athanasian EA, Morris CD, Boland PJ, Healey JH (2009) Allograft-prosthesis composite reconstruction of the proximal part of the humerus: functional outcome and survivorship. J Bone Joint Surg Am 91(10):2406–2415. doi:10.2106/JBJS.H.00815

    PubMed  Google Scholar 

  97. Van de Sande MAJ, Dijkstra PDS, Taminiau AHM (2011) Proximal humerus reconstruction after tumour resection: biological versus endoprosthetic reconstruction. Int Orthop 35(9):1375–1380. doi:10.1007/s00264-010-1152-z

    PubMed Central  PubMed  Google Scholar 

  98. Morrey ME, Sanchez-Sotelo J, Abdel MP, Morrey BF (2013) Allograft-prosthetic composite reconstruction for massive bone loss including catastrophic failure in total elbow arthroplasty. J Bone Joint Surg Am 95(12):1117–1124. doi:10.2106/JBJS.L.00747

    PubMed  Google Scholar 

  99. Donati D, Di Bella C, Frisoni T, Cevolani L, DeGroot H (2011) Alloprosthetic composite is a suitable reconstruction after periacetabular tumor resection. Clin Orthop 469(5):1450–1458. doi:10.1007/s11999-011-1799-9

    PubMed Central  PubMed  Google Scholar 

  100. Benedetti MG, Bonatti E, Malfitano C, Donati D (2013) Comparison of allograft-prosthetic composite reconstruction and modular prosthetic replacement in proximal femur bone tumors: functional assessment by gait analysis in 20 patients. Acta Orthop 84(2):218–223. doi:10.3109/17453674.2013.773119

    PubMed Central  PubMed  Google Scholar 

  101. Farfalli GL, Aponte-Tinao LA, Ayerza MA et al (2013) Comparison between constrained and semiconstrained knee allograft-prosthesis composite reconstructions. Sarcoma 2013:489652. doi:10.1155/2013/489652

    PubMed Central  PubMed  Google Scholar 

  102. Henderson ER, Pepper AM, Marulanda G, Binitie OT, Cheong D, Letson GD (2012) Outcome of lower-limb preservation with an expandable endoprosthesis after bone tumor resection in children. J Bone Joint Surg Am 94(6):537–547. doi:10.2106/JBJS.I.01575

    PubMed  Google Scholar 

  103. Aboulafia AJ, Wilkerson J (2012) Lower-limb preservation with an expandable endoprosthesis after tumor resection in children: is the cup half full or half empty? Commentary on an article by Eric R. Henderson, MD, et al.: “Outcome of lower-limb preservation with an expandable endoprosthesis after bone tumor resection in children.” J Bone Joint Surg Am 94(6):e39. doi:10.2106/JBJS.K.01643

  104. Ritacco LE, Milano FE, Farfalli GL, Ayerza MA, Muscolo DL, Aponte-Tinao LA (2013) Accuracy of 3-D planning and navigation in bone tumor resection. Orthopedics 36(7):e942–e950. doi:10.3928/01477447-20130624-27

    PubMed  Google Scholar 

  105. Cartiaux O, Banse X, Paul L, Francq BG, Aubin C-É, Docquier P-L (2013) Computer-assisted planning and navigation improves cutting accuracy during simulated bone tumor surgery of the pelvis. Comput Aided Surg Off J Int Soc Comput Aided Surg 18(1–2):19–26. doi:10.3109/10929088.2012.744096

    Google Scholar 

  106. Li J, Wang Z, Guo Z, Chen G-J, Yang M, Pei G-X (2013) Precise resection and biological reconstruction under navigation guidance for young patients with juxta-articular bone sarcoma in lower extremity: preliminary report. J Pediatr Orthop. doi:10.1097/BPO.0b013e31829b2f23

    Google Scholar 

  107. Rose PS, Dickey ID, Wenger DE, Unni KK, Sim FH (2006) Periosteal osteosarcoma: long-term outcome and risk of late recurrence. Clin Orthop 453:314–317. doi:10.1097/01.blo.0000229341.18974.95

    PubMed  Google Scholar 

  108. Grimer RJ, Bielack S, Flege S, et al (2005) Periosteal osteosarcoma–a European review of outcome. Eur J Cancer Oxf Engl 1990. 41(18):2806–2811. doi:10.1016/j.ejca.2005.04.052

  109. Briccoli A, Rocca M, Salone M, Guzzardella GA, Balladelli A, Bacci G (2010) High grade osteosarcoma of the extremities metastatic to the lung: long-term results in 323 patients treated combining surgery and chemotherapy, 1985–2005. Surg Oncol 19(4):193–199. doi:10.1016/j.suronc.2009.05.002

    PubMed  Google Scholar 

  110. Bielack SS, Kempf-Bielack B, Branscheid D et al (2009) Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients. J Clin Oncol Off J Am Soc Clin Oncol 27(4):557–565. doi:10.1200/JCO.2008.16.2305

    Google Scholar 

  111. Iwata S, Ishii T, Kawai A et al (2013) Prognostic factors in elderly osteosarcoma patients: a multi-institutional retrospective study of 86 cases. Ann Surg Oncol. doi:10.1245/s10434-013-3210-4

    PubMed  Google Scholar 

  112. Ruggieri P, Calabrò T, Montalti M, Mercuri M (2010) The role of surgery and adjuvants to survival in Pagetic osteosarcoma. Clin Orthop 468(11):2962–2968. doi:10.1007/s11999-010-1473-7

    PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopedic Surgery and Rehabilitation Medicine, The University of Chicago, 5841 South Maryland, MC 3079, Chicago, IL, 60637, USA

    Drew D. Moore & Hue H. Luu

Authors
  1. Drew D. Moore
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hue H. Luu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hue H. Luu .

Editor information

Editors and Affiliations

  1. Department of Orthopaedic Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA

    Terrance D. Peabody

  2. Department of Orthopaedic Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA

    Samer Attar

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Moore, D.D., Luu, H.H. (2014). Osteosarcoma. In: Peabody, T., Attar, S. (eds) Orthopaedic Oncology. Cancer Treatment and Research, vol 162. Springer, Cham. https://doi.org/10.1007/978-3-319-07323-1_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-07323-1_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-07322-4

  • Online ISBN: 978-3-319-07323-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation